{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:08:35Z","timestamp":1747998515241},"reference-count":33,"publisher":"Consilium Medicum","issue":"12","license":[{"start":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T00:00:00Z","timestamp":1576368000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Diabetes mellitus (DM) and chronic liver disease (CLD) are pathological conditions associated with each other and reaching epidemic proportions. There is a strong pathogenetic relationship of carbohydrate metabolism disorders and a number of CLD. Common mechanisms that provoke metabolic and autoimmune disorders in the development of various CLD, leading to steatosis, insulin resistance (IR), impaired glucose tolerance and the development of DM are described. Effective glycemic control can have a beneficial effect on the treatment of these patients, and, conversely, there is evidence of a positive effect of CLD therapy on carbohydrate metabolism. This review discusses the correction of carbohydrate metabolism in patients with CLD, the main groups of modern hypoglycemic drugs, mechanisms of their action, the impact on the physiology of the liver, the possibility of using each of these pharmacological groups in patients with impaired liver function. The modern approaches and possibilities of drug effects on the process of fibrogenesis in CLD, the effect of these drugs on carbohydrate metabolism are listed.<\/jats:p>","DOI":"10.26442\/00403660.2019.12.000166","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T15:59:34Z","timestamp":1593446374000},"page":"115-121","source":"Crossref","is-referenced-by-count":2,"title":["Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features"],"prefix":"10.26442","volume":"91","author":[{"given":"Z A","family":"Kalmykova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I V","family":"Kononenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A Yu","family":"Mayorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2019,12,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03822.x1"},{"key":"ref2","unstructured":"\u0414\u0435\u0434\u043e\u0432 \u0418.\u0418., \u0428\u0435\u0441\u0442\u0430\u043a\u043e\u0432\u0430 \u041c.\u0412. C\u0430\u0445\u0430\u0440\u043d\u044b\u0439 \u0434\u0438\u0430\u0431\u0435\u0442 \u0442\u0438\u043f\u0430 2. \u041e\u0442 \u0442\u0435\u043e\u0440\u0438\u0438 \u043a \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0435. \u041c., 2016."},{"key":"ref3","unstructured":"British National Formulary (BNF) 70. Published 2015. Available at: https:\/\/pharm.reviews\/images\/statyi\/british-national-formulary-2015.pdf (accessed Aug 7, 2018)."},{"key":"ref4","unstructured":"\u0410\u0440\u0443\u0442\u044e\u043d\u043e\u0432 \u0410.\u0422., \u0418\u0432\u0430\u043d\u0438\u043a\u043e\u0432 \u0418.\u041e., \u0421\u044e\u0442\u043a\u0438\u043d \u0412.\u0415. \u0414\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u0435 \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439 \u043f\u0435\u0447\u0435\u043d\u0438. \u041c.: \u041f\u0440\u0438\u043d\u0442-\u0410\u0442\u0435\u043b\u044c\u0435, 2005. 303 \u0441. ISBN 5-98107-020-X."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27199"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2012.07.2574"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0227"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i12.1652"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Kawamori R, Kadowaki T, Onjic M, et al. Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: Postmarketing surveillance study in Japan. Diabetes Res Clin Pract. 2007;76(2):229-35.","DOI":"10.1016\/j.diabres.2006.08.017"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Bril F, Kalavalapalli S, Clark V.C, Lomonaco R.S. Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes. Clin Gastroenterol Hepatol. 2018;16(4):558-66.","DOI":"10.1016\/j.cgh.2017.12.001"},{"key":"ref12","unstructured":"\u0420\u0435\u0433\u0438\u0441\u0442\u0440 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0445 \u0441\u0440\u0435\u0434\u0441\u0442\u0432 \u0420\u043e\u0441\u0441\u0438\u0438 \u0420\u041b\u0421 [Electronic resource]. \u0414\u043e\u0441\u0442\u0443\u043f\u043d\u043e \u043f\u043e \u0441\u0441\u044b\u043b\u043a\u0435: https:\/\/www.rlsnet.ru (\u0434\u0430\u0442\u0430 \u043e\u0431\u0440\u0430\u0449\u0435\u043d\u0438\u044f: 07.08.2018)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1539"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Gentile S, Turco S, Guarino G, et al. Effect of treatment with acarbose and insulin in patients with non - insulin - dependent diabetes mellitus associated with non - alcoholic liver cirrhosis. Diabetes Obes Metab. 2001;3(1):33-40.","DOI":"10.1046\/j.1463-1326.2001.00103.x"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Gentile S, Guarino G, Romano M, et al. A randomized controlled trial of acarbose in hepatic encephalopathy. Clin Gastroenterol Hepatol. 2005;3(2):184-91.","DOI":"10.1016\/S1542-3565(04)00667-6"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1146"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0154-1"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.12.006"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i10.289"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0157-y"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.14341\/DM20171S8"},{"key":"ref23","unstructured":"\u0418\u0432\u0430\u0448\u043a\u0438\u043d \u0412.\u0422., \u042e\u0449\u0443\u043a \u041c.\u0412. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438 \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0430\u0441\u0441\u043e\u0446\u0438\u0430\u0446\u0438\u0438 \u0438 \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0433\u043e \u043e\u0431\u0449\u0435\u0441\u0442\u0432\u0430 \u043f\u043e \u0438\u0437\u0443\u0447\u0435\u043d\u0438\u044e \u043f\u0435\u0447\u0435\u043d\u0438 \u043f\u043e \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0435 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u044e \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0433\u0435\u043f\u0430\u0442\u0438\u0442\u043e\u043c \u0412. \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u0438, \u0433\u0435\u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438, \u043a\u043e\u043b\u043e\u043f\u0440\u043e\u043a\u0442\u043e\u043b\u043e\u0433\u0438\u0438. 2014;(3):5-19."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v8.i35.1557"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1159\/000484237"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00134"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Li Q, Xu B, Michie S.A, Rubins K.H, et al. Interferon alpha initiates type 1 diabetes in nonobese diabetic mice. PNAS. 2008;105(34):12439-44.","DOI":"10.1073\/pnas.0806439105"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.22416\/1382-4376-2017-27-6-20-40"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-015-0060-1"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Chalasani N, Younossi Z, Lavine J.E, et al. The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57.","DOI":"10.1002\/hep.29367"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.05.042"},{"key":"ref32","unstructured":"\u0421\u043c\u0438\u0440\u043d\u043e\u0432\u0430 \u041e.\u041c. \u0421\u0430\u0445\u0430\u0440\u043d\u044b\u0439 \u0434\u0438\u0430\u0431\u0435\u0442 \u0438 \u043d\u0435\u0430\u043b\u043a\u043e\u0433\u043e\u043b\u044c\u043d\u0430\u044f \u0431\u043e\u043b\u0435\u0437\u043d\u044c \u043f\u0435\u0447\u0435\u043d\u0438. \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0430\u043b\u044c\u043c\u0430\u043d\u0430\u0445. 2014:57-61"},{"key":"ref33","unstructured":"\u0421\u043a\u043b\u044f\u043d\u0438\u043a \u0418.\u0410., \u0428\u0430\u043c\u0445\u0430\u043b\u043e\u0432\u0430 \u041c.\u0428., \u0428\u0435\u0441\u0442\u0430\u043a\u043e\u0432\u0430 \u041c.\u0412. \u041f\u043e\u0441\u0442\u0442\u0440\u0430\u043d\u0441\u043f\u043b\u0430\u043d\u0442\u0430\u0446\u0438\u043e\u043d\u043d\u044b\u0439 \u0441\u0430\u0445\u0430\u0440\u043d\u044b\u0439 \u0434\u0438\u0430\u0431\u0435\u0442. \u041e\u0431\u0437\u043e\u0440 \u043b\u0438\u0442\u0435\u0440\u0430\u0442\u0443\u0440\u044b. \u0421\u0430\u0445\u0430\u0440\u043d\u044b\u0439 \u0434\u0438\u0430\u0431\u0435\u0442. 2015;18(2):20-31"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/33755\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/33755\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T21:08:17Z","timestamp":1634159297000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/33755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,15]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,15]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2019.12.000166","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,15]]}}}